Verrica Pharma Files 8-K on Security Holder Rights
Ticker: VRCA · Form: 8-K · Filed: Jul 23, 2025 · CIK: 1660334
| Field | Detail |
|---|---|
| Company | Verrica Pharmaceuticals Inc. (VRCA) |
| Form Type | 8-K |
| Filed Date | Jul 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, filing
Related Tickers: VERR
TL;DR
VERR filed an 8-K, watch for changes to security holder rights.
AI Summary
Verrica Pharmaceuticals Inc. filed an 8-K on July 23, 2025, reporting material modifications to the rights of security holders and financial statements/exhibits as of July 22, 2025. The filing does not contain specific details on the nature of the modifications or the financial exhibits.
Why It Matters
This filing indicates potential changes affecting Verrica Pharmaceuticals' security holders, requiring investors to review the details of any modifications to understand their impact.
Risk Assessment
Risk Level: medium — The filing mentions material modifications to security holder rights, which could have significant implications for investors.
Key Players & Entities
- Verrica Pharmaceuticals Inc. (company) — Registrant
- July 22, 2025 (date) — Earliest event reported
- July 23, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of Incorporation
- 484-453-3300 (phone_number) — Registrant's telephone number
FAQ
What specific material modifications were made to the rights of Verrica Pharmaceuticals Inc. security holders?
The provided filing excerpt does not specify the nature of the material modifications to the rights of security holders.
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported is dated July 22, 2025.
When was this 8-K form filed with the SEC?
This Form 8-K was filed on July 23, 2025.
What is Verrica Pharmaceuticals Inc.'s state of incorporation?
Verrica Pharmaceuticals Inc. is incorporated in Delaware.
What is the principal executive office address for Verrica Pharmaceuticals Inc.?
The principal executive offices are located at 44 West Gay Street, Suite 400, West Chester, PA 19380.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 23, 2025 regarding Verrica Pharmaceuticals Inc. (VRCA).